FDA
-
-
-
-
-
-
-
Absci begins dosing patients in trial of AI-designed hair loss treatment
-
-
-
-
-
-
-
Absci (ABSI) appoints Mary Szela to board of directors
-
-
-
-
-
-
-
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
-
-
-
-
-
-
-
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
-
-
-
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

